PMID- 29465549
OWN - NLM
STAT- MEDLINE
DCOM- 20180302
LR  - 20240316
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Print)
IS  - 0025-7974 (Linking)
VI  - 97
IP  - 8
DP  - 2018 Feb
TI  - Cardiorespiratory parameters and glycated hemoglobin of patients with type 2 
      diabetes after a rehabilitation program.
PG  - e9321
LID - 10.1097/MD.0000000000009321 [doi]
LID - e9321
AB  - INTRODUCTION: Cardiovascular autonomic dysfunction reflex of the pathophysiology 
      of diabetes mellitus (DM) favors an increase in morbidity and mortality related 
      to cardiovascular events, and for this reason has been one of the most studied 
      clinical entities. METHOD: An experimental study of a randomized clinical trial 
      type was therefore proposed to analyze the hemodynamic and glycemic response 
      after the practice of a rehabilitation program in patients with type 2 diabetes 
      mellitus (T2DM). In this clinical trial the patients will initially be submitted 
      to an evaluation protocol that consists of assessing blood pressure, heart rate, 
      Borg scale, respiratory rate, oxygen saturation, distance traveled through the 
      6-minute walk test, quality of life questionnaire, Pittsburgh sleep quality 
      questionnaire, and still glycated hemoglobin and heart rate variability through 
      the cardiofrequency meter. After careful evaluation of the patients, they will be 
      submitted to a metabolic rehabilitation program composed of aerobic and resisted 
      exercises, performed for 12 weeks, in 3 weekly meetings of 60 minutes each. With 
      such evaluations, it will be possible to construct with evidence that it is 
      possible to work safer metabolic rehabilitation programs in patients with T2DM or 
      other diseases that generate cardiovascular risks, guaranteeing them an 
      improvement in cardiorespiratory fitness, hemodynamic and glycemic variables, 
      allowing improvement of the quality of life. ETHICS AND DISSEMINATION: The 
      protocol is approved by the host institution's ethics committee under the number 
      1.616.721. Results will be disseminated via peer-reviewed journal articles and 
      conferences. This clinical trial is registered at ClinicalTrials.gov identifier: 
      NCT3094767.
FAU - Marques, Natalia da Silva Freitas
AU  - Marques NDSF
AD  - Laboratory of Study Design and Scientific Writing of the Faculty of Medicine of 
      ABC, Prince of Wales, Santo Andre/SP-CEP, Brazil Research Laboratory of 
      UNINORTE-Baron College of Rio Branco, Alameda Hungary, Rio Branco/AC-CEP, Brazil.
FAU - Abreu, Luiz Carlos de
AU  - Abreu LC
FAU - Santos, Barbara Vieira Dos
AU  - Santos BVD
FAU - Neto, Candido Ferreira Rodrigues
AU  - Neto CFR
FAU - Silva, Jose Rener Cordeiro da
AU  - Silva JRCD
FAU - Braga, Karine Ketlem de Souza
AU  - Braga KKS
FAU - Uchoa, Kariny da Silva
AU  - Uchoa KDS
FAU - Moraes, Laila Maria Silva
AU  - Moraes LMS
FAU - Ferreira, Leillane Cristina de Paiva
AU  - Ferreira LCP
FAU - Ribeiro, Natanael Guimaraes
AU  - Ribeiro NG
FAU - Santos, Savio Lima Dos
AU  - Santos SLD
FAU - Silva, Tayna Almeida da
AU  - Silva TAD
FAU - Andrade, Paulo Evaristo de
AU  - Andrade PE
FAU - Raimundo, Rodrigo Daminello
AU  - Raimundo RD
LA  - eng
SI  - ClinicalTrials.gov/NCT03094767
SI  - ClinicalTrials.gov/NCT03094767
PT  - Journal Article
PT  - Randomized Controlled Trial
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (hemoglobin A1c protein, human)
SB  - IM
MH  - Adult
MH  - Blood Glucose/analysis
MH  - Blood Pressure
MH  - Clinical Protocols
MH  - *Diabetes Mellitus, Type 2/blood/physiopathology/rehabilitation
MH  - Exercise/*physiology
MH  - Female
MH  - Glycated Hemoglobin/*analysis
MH  - Heart Rate
MH  - Humans
MH  - Male
MH  - Oxygen Consumption
MH  - Quality of Life
MH  - Resistance Training/*methods
MH  - Sleep
MH  - Surveys and Questionnaires
MH  - Treatment Outcome
MH  - Walk Test
PMC - PMC5841997
COIS- The authors have no conflicts of interest to disclose.
EDAT- 2018/02/22 06:00
MHDA- 2018/03/03 06:00
PMCR- 2018/02/23
CRDT- 2018/02/22 06:00
PHST- 2018/02/22 06:00 [entrez]
PHST- 2018/02/22 06:00 [pubmed]
PHST- 2018/03/03 06:00 [medline]
PHST- 2018/02/23 00:00 [pmc-release]
AID - 00005792-201802230-00014 [pii]
AID - MD-D-17-05854 [pii]
AID - 10.1097/MD.0000000000009321 [doi]
PST - ppublish
SO  - Medicine (Baltimore). 2018 Feb;97(8):e9321. doi: 10.1097/MD.0000000000009321.